{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:06:11Z","timestamp":1776384371309,"version":"3.51.2"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Activated protein C (APC) is one of the mechanisms contributing to coagulopathy, which is associated with high mortality. The counteraction of the APC pathway could help ameliorate bleeding. However, patients also transform frequently from a hemorrhagic state to a prothrombotic state at a later time. Therefore, a prohemostatic therapeutic intervention should take this thrombotic risk into consideration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVES<\/jats:title>\n            <jats:p>CT-001 is a novel factor VIIa (FVIIa) with enhanced activity and desialylated N-glycans for rapid clearance. We assessed CT-001 clearance in multiple species and its ability to reverse APC-mediated coagulopathic blood loss.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>The N-glycans on CT-001 were characterized by liquid chromatography\u2013mass spectrometry. Three species were used to evaluate the pharmacokinetics of the molecule. The potency and efficacy of CT-001 under APC pathway\u2013induced coagulopathic conditions were assessed by coagulation assays and bleeding models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>The N-glycosylation sites of CT-001 had high occupancy of desialylated N-glycans. CT-001 exhibited 5 to 16 times higher plasma clearance in human tissue factor knockin mice, rats, and cynomolgus monkeys than wildtype FVIIa. CT-001 corrected the activated partial thromboplastin time and thrombin generation of coagulopathic plasma to normal in in vitro studies. In an APC-mediated saphenous vein bleeding model, 3 mg\/kg of CT-001 reduced bleeding time in comparison with wildtype FVIIa. The correction of bleeding by CT-001 was also observed in a coagulopathic tail amputation severe hemorrhage mouse model. The efficacy of CT-001 is independent of the presence of tranexamic acid, and the combination of CT-001 and tranexamic acid does not lead to increased thrombogenicity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>CT-001 corrected APC pathway\u2013mediated coagulopathic conditions in preclinical studies and could be a potentially safe and effective procoagulant agent for addressing APC-mediated bleeding.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ta.0000000000004079","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T10:00:12Z","timestamp":1687168812000},"page":"276-286","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Rapid clearing CT-001 restored hemostasis in mice with coagulopathy induced by activated protein C"],"prefix":"10.1097","volume":"96","author":[{"given":"Derek S.","family":"Sim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornell R.","family":"Mallari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxine","family":"Bauzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry W.","family":"Hermiston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"bib1-20250806","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/trf.15161","article-title":"Outcomes of traumatic hemorrhagic shock and the epidemiology of preventable death from injury","volume":"59","year":"2019","journal-title":"Transfusion"},{"key":"bib2-20250806","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/SLA.0000000000000837","article-title":"Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the resuscitation outcomes consortium","volume":"261","year":"2015","journal-title":"Ann Surg"},{"key":"bib3-20250806","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/01.TA.0000069184.82147.06","article-title":"Acute traumatic coagulopathy","volume":"54","year":"2003","journal-title":"J Trauma"},{"key":"bib4-20250806","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/01.sla.0000256862.79374.31","article-title":"Acute traumatic coagulopathy: initiated by hypoperfusion","volume":"245","year":"2007","journal-title":"Ann Surg"},{"key":"bib5-20250806","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/SLA.0b013e318235d9e6","article-title":"Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients","volume":"255","year":"2012","journal-title":"Ann Surg"},{"key":"bib6-20250806","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJMoa1802345","article-title":"Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"key":"bib7-20250806","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/TA.0000000000000341","article-title":"Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown","volume":"77","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"key":"bib8-20250806","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/SLA.0000000000004563","article-title":"Evidence-based and clinically relevant outcomes for hemorrhage control trauma trials","volume":"273","year":"2021","journal-title":"Ann Surg"},{"key":"bib9-20250806","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/TA.0000000000001333","article-title":"Damage control resuscitation in patients with severe traumatic hemorrhage","volume":"82","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"bib10-20250806","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","year":"2010","journal-title":"N Engl J Med"},{"key":"bib11-20250806","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0039-1701016","article-title":"Temporal changes in fibrinolysis following injury","volume":"46","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"bib12-20250806","doi-asserted-by":"crossref","first-page":"e12530","DOI":"10.1002\/rth2.12530","article-title":"In vitro characterization of CT-001\u2014a short-acting factor VIIa with enhanced prohemostatic activity","volume":"5","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"bib13-20250806","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.thromres.2022.05.007","article-title":"CT-001 is a rapid clearing factor VIIa with enhanced clearance and hemostatic activity for the treatment of acute bleeding in non-hemophilia settings","volume":"215","year":"2022","journal-title":"Thromb Res"},{"key":"bib14-20250806","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","year":"2010","journal-title":"Comput Methods Programs Biomed"},{"key":"bib15-20250806","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1365-2516.2012.02780.x","article-title":"A sensitive venous bleeding model in haemophilia a mice: effects of two recombinant FVIII products (N8 and Advate\u00ae)","volume":"18","year":"2012","journal-title":"Haemophilia"},{"key":"bib16-20250806","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","year":"2001","journal-title":"J Appl Toxicol"},{"key":"bib18-20250806","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-021-00264-3","article-title":"Trauma-induced coagulopathy","volume":"7","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"bib19-20250806","first-page":"294","article-title":"Can thrombelastography predict venous thromboembolic events in patients with severe extremity trauma?","volume":"30","year":"2016","journal-title":"J Orthop Trauma"},{"key":"bib20-20250806","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.amjsurg.2013.07.024","article-title":"Hypercoagulability following blunt solid abdominal organ injury: when to initiate anticoagulation","volume":"206","year":"2013","journal-title":"Am J Surg"},{"key":"bib21-20250806","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.amjsurg.2019.08.024","article-title":"It's sooner than you think: blunt solid organ injury patients are already hypercoagulable upon hospital admission \u2014 results of a bi-institutional, prospective study","volume":"218","year":"2019","journal-title":"Am J Surg"},{"key":"bib22-20250806","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/TA.0000000000001466","article-title":"Thrombin generation profiles as predictors of symptomatic venous thromboembolism after trauma","volume":"83","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"bib23-20250806","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1097\/AS9.0000000000000167","article-title":"Proteomics of coagulopathy following injury reveals limitations of using laboratory assessment to define trauma-induced coagulopathy to predict massive transfusion","volume":"3","year":"2022","journal-title":"Ann Surg Open"},{"key":"bib24-20250806","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ccc.2016.08.003","article-title":"Coagulopathy of trauma","volume":"33","year":"2017","journal-title":"Crit Care Clin"},{"key":"bib25-20250806","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"bib26-20250806","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archsurg.2011.287","article-title":"Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study","volume":"147","year":"2012","journal-title":"Arch Surg"},{"key":"bib27-20250806","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/jth.14148","article-title":"Abrogating fibrinolysis does not improve bleeding or rFVIIa\/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents","volume":"16","year":"2018","journal-title":"J Thromb Haemost"},{"key":"bib28-20250806","first-page":"104","article-title":"The diamond of death: hypocalcemia in trauma and resuscitation","volume":"41","year":"2020","journal-title":"Am J Emerg Med"},{"key":"bib29-20250806","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/SHK.0b013e3181a5a632","article-title":"Increase in activated protein C mediates acute traumatic coagulopathy in mice","volume":"32","year":"2009","journal-title":"Shock"},{"key":"bib30-20250806","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/bloodadvances.2021005257","article-title":"An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice","volume":"6","year":"2022","journal-title":"Blood Adv"},{"key":"bib31-20250806","first-page":"H1166","article-title":"Trauma-hemorrhage and resuscitation in the mouse: effects on cardiac output and organ blood flow","volume":"264","year":"1993","journal-title":"Am J Physiol"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:10:53Z","timestamp":1754496653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000004079","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,19]]}}}